Furthermore, the GLP-1R agonist, liraglutide, increases survival in experimental MI, and cardiac function after ischaemia–reperfusion injury is improved in DPP-4−/− mice [15, 17]. The gene discussed is DPP4; the disease is myocardial infarction.